pioneering pharmaceuticals

making pharmaceuticals more affordable, more available, and better than before

Innovative solutions along the entire pharmaceutical value chain
As part of the TIEFENBACHER GROUP, a 100% family-owned leading health care company, we provide solutions throughout the entire life cycle of a pharmaceutical product. We develop, manufacture, and register generic, value added and innovative medicines and license them out to marketing partners worldwide. The world´s most trusted brands count on our high excellence in creating best-in-class-dossiers and our ability to manage complex launches in over 80 countries worldwide. Our own laboratories and manufacturing sites in India and Cyprus empower us to build up efficient supply chains resulting in best value for money for our customers. Furthermore we are commited for growth and innovation by offering a well-defined and specialized portfolio of highly potent drugs.
There is one purpose driving TIEFENBACHER´s over 600 employees day by day: improving the life of millions of patients worldwide by making pharmaceuticals more affordable, more available, and better than before.

OUT-Licensing of generic, value added and innovative medicines

Our Business Model: From initial idea to patient

Advance tomorrow´s medicine with us!

We, at AET TIEFENBACHER PHARMACEUTICALS, develop, manufacture, and register generic, value added and innovative medicines and license them out to marketing partners worldwide. We have a proven track record in licensing-out in-house-developed dossiers to customers around the world – from local to global players. Our fully integrated service includes research and market intelligence, API sourcing, intellectual property, FDF development, clinical trials, registration, quality assurance as well as supply chain management for a successful market access.

We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms as well as additional medical devices and drug device combinations. Whether for widespread or for orphan diseases – we are not limited to specific disease areas, we are focusing on what will truly deliver an impact and value for patients.

Gain access to novel healthcare solutions, speed up time-to-market and open up unexplored business opportunities with us! Get a reliable and cost-efficient supply and let us build your portfolio globally! AET TIEFENBACHER PHARMACEUTICALS is changing tomorrow´s health by making pharmaceuticals more affordable, more available and better than before!

A part of TIEFENBACHER GROUP: Our Purpose

We are pioneering healthcare to improve patients' lives around the world

tb-icon-IN-OUT-loop-negativ

Living our purpose – it gives meaning to everything we do

We believe that the global access to affordable high-quality healthcare is a human right. That’s why we are lead in everything we do by three questions: are we making high-quality pharmaceuticals better affordable, better globally available, and better than before? This clear purpose has deep and enduring value. It gives us the reason to come to work every day and reminds us why we exist as a company – to make a change in tomorrow ́s health.

With purpose for people and a better world

affort

Better Affordability

avail

Better Global Availability

Better Therapy

affort

Better Affordability

avail

Better Global Availability

Better Therapy

Tiefenbacher Group: Our Company

Best-in-class solutions along the entire pharmaceutical value chain

To achieve our purpose – to improve patients ́ lives worldwide – we have an agile, vertically integrated company structure. From initial idea to market access: We constantly look for smart and better ways to excel – to achieve solutions for current and future unmet needs. Our 100% family-owned company structure enhances the power of each individual division and enables us to respond quickly to the evolving demands of the market. Our broad competence allows us to connect ideas and expertise to create novel, patient-centric healthcare solutions and to bring them extremely fast to patients. This agile and vertically integrated organization structure empowers us to pioneer healthcare holistically.

Tiefenbacher Group: Organization structure

Best-in-class solutions along the entire pharmaceutical value chain

To achieve our purpose – to improve patients ́ lives worldwide – we have an agile, vertically integrated company structure. From initial idea to market access: We constantly look for smart and better ways to excel – to achieve solutions for current and future unmet needs. Our 100% family- owned company structure enhances the power of each individual division and enables us to respond quickly to the evolving demands of the market. Our broad competence allows us to connect ideas and expertise to create novel, patient-centric healthcare solutions and to bring them extremely fast to patients. This agile and vertically integrated organization structure empowers us to pioneer healthcare holistically.

From Initial Idea To Market Access of High-Quality Pharmaceuticals

Raw Material

R&D

Manufacturing

Medical Device

Market Access

Our agile cross-functional company structure makes us stronger and better to change tomorrow’s health together

We, at TIEFENBACHER GROUP, have often demonstrated to excel in our field, to retain talent, and to innovate fastest. Our broad competence and vertical company structures enables us to pioneer healthcare holistically. We are pushing beyond what’s possible – always from a patient-centric approach – and are bringing forward novel healthcare solutions for people around the world.

Organization structure at TIEFENBACHER GROUP

Our company values: curiosity driven – excellence focused – patient centered

The courage to shape a better futureAlways one step ahead – this is how we work, this is how we think

Our values define who we are and what special attitudes we have as individuals and together as an organization to achieve our purpose. They guide us in all we do. 

We believe that our expertise has to be leveraged for greater good – to improve patients’ lives worldwide. Our three values are central to how we behave as individuals, and collectively as an organization to achieve our purpose by making high-quality pharmaceuticals more affordable more available, and better than before.
We, within the evolved international TIEFENBACHER company structure, are many, working as one across functions, across companies, and across the world.
Our purpose and our values tie us together as a company and drive us to keep aiming for making an impact: from initial idea to market access – providing best-in-class solutions along the entire pharmaceutical value chain. By working together as TIEFENBACHER GROUP, in agile collaboration and cross-function structures, we tap into our full potential and stay at the forefront of our field.

Our three values in action mean:

junge_Gluehbirne
Blitzbirne

CuriosityDriven

Achiever by pioneership

>

maedchen_mit_brille

Excellencefocused

Know-How by enthusiasts

>

hand und herz

Patientcentered

Value by innovations

>

junge_Gluehbirne
Blitzbirne

Pioneership

Achieverby curiosity

>

maedchen_mit_brille

Excellence

Know-Howby enthusiasts

>

junge_erfreut
hand und herz

Patient Focus

Value byInnovations

>

Our people: diverse, curiosity-driven and with passion for healthcare

Experts and enthusiasts to improve people's lives worldwide

The greatest strength of TIEFENBACHER GROUP are our people. We believe that their curiosity, their passion for healthcare, and their diversity are the foundation of our sucess. 

Everything we do at TIEFENBACHER GROUP is dedicated to improving the lives of patients around the world. We are there to make a difference. That’s why all our activities are focused on creating pharmaceuticals more available, more affordable, and better than before. The curiosity and passion of each of us is the driving force for our pioneering role. We welcome the diversity of nationalities, languages, cultures, and lifestyles in which we work together as one organization – that’s how we have a positive and effective impact on one another throughout the entire organization.

By working together as TIEFENBACHER GROUP, in flexible and agile cross-functional structures, we tap into our full potential, drive our success, and make us stay at the forefront of our field – to make advanced, value-driven pharmaceutical solutions available to everyone around the globe.

>800

Headcount

>25

Nationalities

>45%

University degree
in Natural Science

Our products: Raw Material – Finished Dosage Forms – Medical Devices

Better healthcare products through a patient-centric approach

Our portfolio covers all relevant pharmaceutical categories: It includes raw materials, finished dosage forms like tablets, capsules, powders, drops, and patches as well as medical devices. We are not limited to specific disease areas – we are focusing on what will truly deliver an impact and value for patients – whether for widespread or for orphan diseases. 

Our purpose – to improve patients’ lives around the world – ties us together as a company and drives us to deliver better healthcare to people with our products and services. We, at TIEFENBACHER GROUP, are proud of our longstanding experience to take pharmaceuticals through the entire value chain: from the initial idea to market access of high-quality medicines around the world. We distribute 600+ APIs and develop in-house finished dosage forms (FDF) and drug device combinations that address specific therapeutic needs – in unique formulations of prescription drugs (Rx) as well as over-the-counter (OTC) medicines. Our FDF portfolio covers over 180+ products across various therapeutic categories in 10+ dosage forms. With our innovative medical device solutions we are revolutionizing the way patients are treated by combining high-quality drug device combinations with novel e-health solutions. Our business approach is based on understanding the environment in which our products are intended to be used. We are experts in adjusting to specific local requirements and customer challenges to ensure that our healthcare solutions make a sustainable impact – for the benefit for patients worldwide.

By working together as TIEFENBACHER GROUP, in flexible and agile cross-functional structures, we tap into our full potential, drive our success, and make us stay at the forefront of our field – to make advanced, value-driven pharmaceutical solutions available to everyone around the globe.

BEST-IN-CLASS PRODUCTS THAT DELIVER BETTER HEALTHCARE

Improving patients' lives through sustainable business

Corporate Responsibility at TIEFENBACHER GROUP

We, at TIEFENBACHER GROUP, know that our responsibility as a global healthcare company goes beyond medicine. We understand sustainability as behaving responsibly towards society and our planet – in our day-to-day work. Being commercial successful and operating responsibly is how we will generate sustainable returns.

By creating innovative high-quality medicines with broad access to patients around the world and providing a safe and rewarding workplace we can use our business to build a better tomorrow. We guarantee highest quality standards for our products and processes and ensure that TIEFENBACHER GROUP acts in compliance with applicable regulations, laws, policies, and guidelines. We promote ethical and trustful behavior by all employees of TIEFENBACHER GROUP. Furthermore, we strive to make efficient use of natural resources, to minimize the environmental impact of our operations, and to invest in environmental solutions that drive a circular economy. We also care about our society – especially in the countries where our company operates. Our caring culture is fundamental to achieve our purpose to make life significantly better for people around the world.

We demonstrate our commitment to doing business responsibly in a very meaningful and tangible way by building a healthier and more sustainable future. Check out how we act responsibly in our daily business within the TIEFENBACHER GROUP to fulfill our purpose of improving patients´ lives in a sustainable way:

happy_family

For us at TIEFENBACHER GROUP, compliance means more than adhering to legal requirements, voluntary obligations and internal company guidelines. Compliance is a question of attitude: reliability, honesty, credibility, and integrity are part of our DNA and the basis of our sustainable business success.

The Code of Conduct and the Whistleblower Platform are two important components of our corporate governance.
Our Code of Conduct describes how we want to do business at TIEFENBACHER GROUP. It provides guidance on how to deal with the most important integrity and legal issues in our daily work – with our colleagues, our customers, our business partners, and other third parties.

With our Whistleblower Platform TIEFENBACHER GROUP offers employees and external stakeholders the opportunity to report violations of legal provisions and internal company regulations anonymously. Every report is examined in detail by an external body, suspicious cases are investigated, and any infringements are consistently pursued. Our Whistleblower Portal is a dedicated communication channel operated by a third party and available 24 hours a day, 365 days a year.

Our history: Pioneering Healthcare since 1963

AT A GLANCE: OUR MILESTONES AND GONTINUED GROWTH AT TIEFENBACHER GROUP

From a distributor of Active Pharmaceutical Ingredients (APIs) to a purpose-driven healthcare company with a global footprint.

We have always been powered by a strong commitment to make a difference with our products and services. Founded in 1963 as the world’s first exclusive agency for active pharmaceutical ingredients (APIs), Tiefenbacher has been grown into a leading healthcare company providing innovative and best-in-class solutions along the entire pharmaceutical value chain. Representing API producers has provided the foundation for Tiefenbacher´s growth into an international operating, vertically integrated pharmaceutical company. From initial idea to market access: Today we distribute APIs and develop, manufacture, and register finished dosage forms (FDFs) as well as medical devices. In over 55 years of our company history, we have shown an outstanding track record in anticipating new developments as well as launching new businesses.

Please haven an overview about our milestones and how we, TIEFENBACHER GROUP, are pioneering healthcare – and contribute to people for a better tomorrow.

Preloader
  • Foundation by Alfred E. Tiefenbacher (API distribution)

    Foundation by Alfred E. Tiefenbacher (API distribution)

  • First generic drug development of finished dosage form

    First generic drug development of finished dosage form

  • Opening of AET Laboratories India ​(R&D and Manufacturing)

    Opening of AET Laboratories India ​(R&D and Manufacturing)

  • Acquisition of Delorbis Cyprus (Manufacturing/ Branded Pharmaceuticals)

    Acquisition of Delorbis Cyprus (Manufacturing/ Branded Pharmaceuticals)

  • Foundation of AET Pharma Inc. USA

    Foundation of AET Pharma Inc. USA 

  • Launch of axunio Pharma (Branded Pharmaceuticals)

    Launch of axunio Pharma (Branded Pharmaceuticals)

  • Foundation of Tiefenbacher Medical Devices

    Foundation of Tiefenbacher Medical Devices

  • First NCE approval for innovative sleeping medicine

    First NCE approval for innovative sleeping medicine

  • First development of a drug/device combination for personalized treatment

    First development of a drug/device combination for personalized treatment

  • Site Expansion at Delorbis Cyprus

    Site Expansion at Delorbis Cyprus

  • High Potent Lab and Site Construction at AET Laboratories India

    High Potent Lab and Site Construction at AET Laboratories India

Our founder Alfred E. Tiefenbacher

Pioneer of the pharmaceutical industry

Our entrepreneurial spirit is firmly anchored in our founder and owner family since 1963.

The foundation of TIEFENBACHER GROUP´s success story was the pioneer spirit of the company´s founder and namesake Alfred E. Tiefenbacher (*1917, +1993). Until today his unique entrepreneur mind is our driving force of achieving better health solutions by always challenging the status quo – in terms of business models as well as concrete products and services.

As we have growing, we are proud to have maintained the agile, entrepreneurial spirit on which we were founded, continuously evolving with our customers and the industry to expand our services and network. Through all of this, we continue to exercise the same level of flexibility and responsiveness that is embedded in our DNA. This combination translates to superior quality to make pharmaceuticals more affordable, more available, and better than before.

AET TIEFENBACHER PHARMACEUTICALS Management

our managing directors

Tiefenbacher Pharmaceuticals, as a part of the TIEFENBACHER GROUP, is led by a team of two executives who share the same purpose of making medicines more affordable, more available throughout the world and better than before. Their combined professional backgrounds and enthusiastic curiosity for people and new ideas drive our pioneership in improving patients’ live around the world.

Dr. Kristian Ruepp

Kristian has held various positions in the pharmaceutical industry. He was able to contribute to the development, production, and control up to the international marketing of pharmaceuticals – recently as managing director of an internationally operating pharmaceutical company. Kristian joined Alfred E. Tiefenbacher in 2018 and is responsible for the pharmaceutical functions and marketing. 

Kristian is married and father of three. 

Oliver Schrader

Oliver spent the vast majority of his global career in the branded consumer goods industry. Besides leading functions in marketing and sales he served as managing director of German Dax and skin care company Beiersdorf in Ukraine, South Africa and North America. Oliver joined the TIEFENBACHER GROUP in 2016 and is overlooking all commercial topics. 

Oliver is married and a father of three. 

Dr. Kristian Ruepp

Kristian has held various positions in the pharmaceutical industry. He was able to contribute to the development, production and control up to the international marketing of pharmaceuticals – recently as managing director of an internationally operating pharmaceutical company. Kristian joined Alfred E. Tiefenbacher in 2018 and is responsible for the pharmaceutical functions and marketing. 

Kristian is married and father of three. 

Oliver Schrader

Oliver spent the vast majority of his global career in the branded consumer goods industry. Besides leading functions in marketing and sales he served as managing director of German Dax and skin care company Beiersdorf in Ukraine, South Africa and North America. Oliver joined the TIEFENBACHER GROUP in 2016 and is overlooking all commercial topics. 

Oliver is married and a father of three. 

Global Presence –in over 80 countries

TIEFENBACHER PHARMACEUTICALS is making medicines more affordable, more available, and better than before.

Tiefenbacher Group

Webcam Hamburg

Contact – AET TIEFENBACHER PHARMACEUTICALS

As the builders of the future, we are working to improve people´s lives worldwide. By thinking beyond healthcare we are making medicines more affordable, more available, and better than before.Please contact us by filling out the contact form below and clicking “Send message”, or directly send an email to info@aet.eu. AET TIEFENBACHER PHARMACEUTICALS will follow up with you personally as soon as possible.




    ALFRED E. TIEFENBACHER (GmbH & Co. KG)
    Van-der-Smissen-Strasse 1
    22767 Hamburg
    Germany

    Phone: +49 40 – 44 18 09 – 0
    Fax: +49 40 – 44 18 09 – 26
    Mail: info@aet.eu